Please login to the form below
Improving diversity in clinical trial patient recruitment
A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many studies find diverse patient recruitment challenging and this can have major implications.
On the 24th February 2022, Kate Shaw, Innovative Trials' Founder and CEO, along with Jane Thurston, Senior Patient Recruitment Lead for Parexel, and Sandra Amaro, Global Clinical Trial Diversity Team Lead for Pfizer, discussed the challenges of recruiting people from underrepresented communities and what can be done in practice to tackle this.
Read more here
Company Details
Innovative Trials
Address:
Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
Hertfordshire
SG6 2WW
United Kingdom
Latest content on this profile
- Kate Shaw comments the appointment of an independent review on clinical trials in the UK.
- The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five years.
Innovative Trials
- Patient Recruitment: Think Global, Act Local
- Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust data - but also promotes health equity and research and innovation across continents.Another benefit of global clinical trials is the potential for these studies to be completed more quickly and efficiently [1]. However, around four in five clinical trials fail to meet their patient recruitment deadlines [2], which delays patient access to innovative new therapeutics and can prove costly to Sponsors.Just as treatments are becoming more personalized, so should clinical trial patient recruitment strategies. A ‘one size fits all’ approach to enrollment fails to consider how factors such as an individual country’s culture, healthcare structure and patients’ needs can affect a site’s ability to recruit eligible participants. The key to patient enrollment success is to ‘think local’, even for global studies.In this webinar, we will:Discuss the benefits of using a diversified patient recruitment approach for each country within a global studyInvestigate how patient recruitment strategies can differ from country to country,Hear from two in-country patient recruitment specialists about the challenges relevant to their regions and how they work with sites to overcome theseShare how Innovative Trials’ ‘boots-on-the-ground’ approach in more than 70 countries around the world can help accelerate patient recruitment and retention for your clinical trials.SpeakersGeorgia Hardy - Site Operations Lead, Innovative TrialsNicole Yingst - Associate Director, Patient Recruitment Programs, PfizerBarbara OrlosKaminska - Clinical Enrollment Manager (Poland), Innovative Trials
Innovative Trials
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.
Innovative Trials
- Kate Shaw reflects on Innovative Trials' first US office openings
- On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening
Innovative Trials
- Innovative Trials on the latest ABPI report
- Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report
Innovative Trials
- Innovative Trials featuring in a Clinical Trials Arena article
- Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.
Innovative Trials
